Streck CE-Marked Kits Detect More than 450 β Lactamase Gene Targets
Streck’s new line of CE-marked antibiotic resistance monitoring and detection (ARM-D) kits are now available. The Streck ARM-D® Kits, ampC and β-Lactamase are multiplex real-time PCR reagents for the detection of more than 450 β lactamase gene targets. The kits are For Export Only. Not for sale in the U.S.
The Streck ARM-D Kits detect the presence of antibiotic resistance genes in bacteria that cause difficult-to-treat infections and that have the ability to spread quickly, especially in a hospital environment. The Streck ARM-D Kits can detect the presence of resistance mechanisms of current clinical importance, such as carbapenemases and extended spectrum β-Lactamases (ESBLs) and some emerging threats, such as the AmpC cephalosporinases. Current phenotypic methods may mischaracterize or fail to detect genetic mechanisms of antibiotic resistance. The Streck ARM-D Kits are a genotypic detection method that can be used to identify the most prevalent types of β-lactamase-based antibiotic resistance.
Streck developed the ARM-D Kits to provide laboratories with a comprehensive, cost-effective molecular method to detect the most clinically-important β-lactamases known to cause therapeutic failure. These kits can be used to complement standard susceptibility tests, improve surveillance and epidemiologic tracking, and also foodborne pathogen and waste water testing.
Tags: Extended-Spectrum Beta-Lactamase ESBL, Antibiotic Resistance
Date Published: February 7, 2017
Source article link: Streck » company contact details
COPAN Diagnostics Inc. Showcasing PhenoMATRIX™ Smart Algorithms at AACC in San Diego
New IUL Colony Counter Automatically Adjusts for Colony and Agar Type
Consortium Secures Innovate UK Funding for Bacteriocins
Disks for Simple, Efficient Confirmation of CPE and OXA-48